Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,105,671 articles, preprints and more)

Suggested authors matching "AUTH:Yarden Y" with an ORCID

Yasmin Yarden
Hebrew University of Jerusalem Faculty of Science
2
Publications
22
Citations
View profile
Yosef yarden
No affiliation detected
1
Publication
374
Citations
View profile

Search results

1-25 of 365 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib.
Simoni-Nieves A, Lindzen M, Giri S, Gupta N, Chatterjee R, Selvadurai BR, Van Daele M, Love D, Haga Y, Romaniello D, Salame TM, Zerbib M, Oren R, Tsutsumi Y, Lauriola M, Marrocco I, Yarden Y
Cell Rep Med, 5(9):101703, 30 Aug 2024
Cited by: 0 articles | PMID: 39216477 | PMCID: PMC11528239
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer.
Bojmar L, Zambirinis CP, Hernandez JM, Chakraborty J, Shaashua L, Kim J, Johnson KE, Hanna S, Askan G, Burman J, Ravichandran H, Zheng J, Jolissaint JS, Srouji R, Song Y, Choubey A, Kim HS, Cioffi M, van Beek E, [...] Lyden D
Nat Med, 30(8):2170-2180, 28 Jun 2024
Cited by: 5 articles | PMID: 38942992 | PMCID: PMC11416063
Add to export list Free full text in Europe PMC
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
Pradeep C-, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y
Oncogene, 43(17):1317, 01 Apr 2024
Cited by: 0 articles | PMID: 38418546
Add to export list
Optogenetics-integrated gut organ culture system connects enteric neurons dynamics and gut homeostasis
Naim G, Romano H, Amidror S, Levy DJ, Cohen A, Sochen C, Yarden Y, Feng M, Farah N, Tsentsarevsky R, Brodie Z, Reich Y, Simon A, Toister E, Shoval I, Mandel Y, Biton M, Yissachar N
bioRxiv, 30 Mar 2024
Cited by: 0 articles | PPR: PPR829779
Add to export list Preprint
Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.
Nevo S, Frenkel N, Kadouri N, Gome T, Rosenthal N, Givony T, Avin A, Peligero Cruz C, Kedmi M, Lindzen M, Ben Dor S, Damari G, Porat Z, Haffner-Krausz R, Keren-Shaul H, Yarden Y, Munitz A, Leshkowitz D, Goldfarb Y, Abramson J
Sci Immunol, 9(91):eabq6930, 12 Jan 2024
Cited by: 7 articles | PMID: 38215193
Add to export list
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
Beumers L, Vlachavas EI, Borgoni S, Schwarzmüller L, Penso-Dolfin L, Michels BE, Sofyali E, Burmester S, Heiss D, Wilhelm H, Yarden Y, Helm D, Will R, Goncalves A, Wiemann S
NPJ Breast Cancer, 9(1):97, 02 Dec 2023
Cited by: 0 articles | PMID: 38042915 | PMCID: PMC10693625
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators.
Marrocco I, Yarden Y
Cancers (Basel), 15(20):5009, 16 Oct 2023
Cited by: 3 articles | PMID: 37894376 | PMCID: PMC10605519
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
Gershoni A, Hassin O, Nataraj NB, Baruch S, Avioz-Seligman A, Pirona AC, Fellus-Alyagor L, Meir Salame T, Mukherjee S, Mallel G, Yarden Y, Aylon Y, Oren M
Mol Oncol, 17(12):2675-2693, 16 Oct 2023
Cited by: 0 articles | PMID: 37716913 | PMCID: PMC10701768
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Selective arm-usage of pre-miR-1307 dysregulates angiogenesis and contributes to breast cancer aggressiveness
Sumer OE, Schelzig K, Jung J, Li X, Moros J, Schwarzmüller L, Sen E, Karolus S, Wörner A, Nataraj NB, Vlachavas E, Gerhäuser C, Müller-Decker K, Helm D, Yarden Y, Michels BE, Körner C
Research Square, 25 Sep 2023
Cited by: 0 articles | PPR: PPR730578
Add to export list Preprint v1
Regulation of nucleo-cytosolic 26S proteasome translocation by aromatic amino acids via mTOR is essential for cell survival under stress.
Livneh I, Cohen-Kaplan V, Fabre B, Abramovitch I, Lulu C, Nataraj NB, Lazar I, Ziv T, Yarden Y, Zohar Y, Gottlieb E, Ciechanover A
Mol Cell, 83(18):3333-3346.e5, 01 Sep 2023
Cited by: 6 articles | PMID: 37738964
Add to export list
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.
Marrocco I, Giri S, Simoni-Nieves A, Gupta N, Rudnitsky A, Haga Y, Romaniello D, Sekar A, Zerbib M, Oren R, Lindzen M, Fard D, Tsutsumi Y, Lauriola M, Tamagnone L, Yarden Y
Cell Rep Med, 4(8):101142, 08 Aug 2023
Cited by: 5 articles | PMID: 37557179 | PMCID: PMC10439256
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Computational optimization of antibody humanness and stability by systematic energy-based ranking.
Tennenhouse A, Khmelnitsky L, Khalaila R, Yeshaya N, Noronha A, Lindzen M, Makowski EK, Zaretsky I, Sirkis YF, Galon-Wolfenson Y, Tessier PM, Abramson J, Yarden Y, Fass D, Fleishman SJ
Nat Biomed Eng, 8(1):30-44, 07 Aug 2023
Cited by: 10 articles | PMID: 37550425
Add to export list
Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
Hedegger K, Blutke A, Hommel T, Auer KE, Nataraj NB, Lindzen M, Yarden Y, Dahlhoff M
Mol Oncol, 17(11):2415-2431, 14 Jul 2023
Cited by: 0 articles | PMID: 37341059 | PMCID: PMC10620123
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Methyl-CpG binding domain 2 (Mbd2) is an epigenetic regulator of autism-risk genes and cognition.
Lax E, Do Carmo S, Enuka Y, Sapozhnikov DM, Welikovitch LA, Mahmood N, Rabbani SA, Wang L, Britt JP, Hancock WW, Yarden Y, Szyf M
Transl Psychiatry, 13(1):259, 13 Jul 2023
Cited by: 2 articles | PMID: 37443311
Add to export list
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets
Wiemann S, Beumers L, Vlachavas E, Borgoni S, Schwarzmüller L, Penso-Dolfin L, Michels B, Sofyali E, Burmester S, Heiss D, Wilhelm H, Yarden Y, Helm D, Will R, Goncalves A
Research Square, 25 May 2023
Cited by: 0 articles | PPR: PPR666328
Add to export list Preprint v1
Immune clustering reveals molecularly distinct subtypes of lung adenocarcinoma
Lender Y, Givton O, Bornshten R, Azar M, Moscona R, Yarden Y, Rubin E
bioRxiv, 17 Apr 2023
Cited by: 0 articles | PPR: PPR645633
Add to export list Preprint
Author Correction: Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Aylon Y, Furth N, Mallel G, Friedlander G, Nataraj NB, Dong M, Hassin O, Zoabi R, Cohen B, Drendel V, Salame TM, Mukherjee S, Harpaz N, Johnson R, Aulitzky WE, Yarden Y, Shema E, Oren M
Nat Commun, 14(1):133, 10 Jan 2023
Cited by: 0 articles | PMID: 36627302 | PMCID: PMC9832168
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Breast cancer plasticity is restricted by a LATS1-NCOR1 repressive axis.
Aylon Y, Furth N, Mallel G, Friedlander G, Nataraj NB, Dong M, Hassin O, Zoabi R, Cohen B, Drendel V, Salame TM, Mukherjee S, Harpaz N, Johnson R, Aulitzky WE, Yarden Y, Shema E, Oren M
Nat Commun, 13(1):7199, 28 Nov 2022
Cited by: 3 articles | PMID: 36443319 | PMCID: PMC9705295
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
Noronha A, Belugali Nataraj N, Lee JS, Zhitomirsky B, Oren Y, Oster S, Lindzen M, Mukherjee S, Will R, Ghosh S, Simoni-Nieves A, Verma A, Chatterjee R, Borgoni S, Robinson W, Sinha S, Brandis A, Kerr DL, Wu W, [...] Yarden Y
Cancer Discov, 12(11):2666-2683, 01 Nov 2022
Cited by: 45 articles | PMID: 35895872 | PMCID: PMC9627128
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies.
Bergado-Báez G, Gonzalez Suarez N, García LC, Pérez-Martínez D, Hernández-Fernández DR, Fundora-Barrios T, Rodríguez-Álvarez A, Díaz-Ordaz GD, Lindzen M, Yarden Y, Sánchez-Ramírez B
Front Oncol, 12:951267, 02 Nov 2022
Cited by: 1 article | PMID: 36408164 | PMCID: PMC9667895
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Reliable energy-based antibody humanization and stabilization
Tennenhouse A, Khmelnitsky L, Khalaila R, Yeshaya N, Noronha A, Lindzen M, Makowski E, Zaretsky I, Sirkis YF, Galon-Wolfenson Y, Tessier PM, Abramson J, Yarden Y, Fass D, Fleishman SJ
bioRxiv, 15 Aug 2022
Cited by: 0 articles | PPR: PPR532642
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.
Hassin O, Nataraj NB, Shreberk-Shaked M, Aylon Y, Yaeger R, Fontemaggi G, Mukherjee S, Maddalena M, Avioz A, Iancu O, Mallel G, Gershoni A, Grosheva I, Feldmesser E, Ben-Dor S, Golani O, Hendel A, Blandino G, Kelsen D, [...] Oren M
Nat Commun, 13(1):2800, 19 May 2022
Cited by: 25 articles | PMID: 35589715 | PMCID: PMC9120190
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
Li X, Michels BE, Tosun OE, Jung J, Kappes J, Ibing S, Nataraj NB, Sahay S, Schneider M, Wörner A, Becki C, Ishaque N, Feuerbach L, Heßling B, Helm D, Will R, Yarden Y, Müller-Decker K, Wiemann S, Körner C
J Exp Clin Cancer Res, 41(1):190, 02 Jun 2022
Cited by: 3 articles | PMID: 35655310 | PMCID: PMC9161486
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.
Mukherjee S, Maddalena M, Lü Y, Martinez S, Nataraj NB, Noronha A, Sinha S, Teng K, Cohen-Kaplan V, Ziv T, Arandkar S, Hassin O, Chatterjee R, Pirona AC, Shreberk-Shaked M, Gershoni A, Aylon Y, Elazar Z, Yarden Y, [...] Oren M
Proc Natl Acad Sci U S A, 119(17):e2119644119, 19 Apr 2022
Cited by: 14 articles | PMID: 35439056 | PMCID: PMC9173583
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans.
Vicencio JM, Evans R, Green R, An Z, Deng J, Treacy C, Mustapha R, Monypenny J, Costoya C, Lawler K, Ng K, De-Souza K, Coban O, Gomez V, Clancy J, Chen SH, Chalk A, Wong F, Gordon P, [...] Ng T
Cell Death Dis, 13(3):274, 28 Mar 2022
Cited by: 12 articles | PMID: 35347108 | PMCID: PMC8960767
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 365 results

1 2 3 Next ...

Search life-sciences literature (45,105,671 articles, preprints and more)

Suggested authors matching "AUTH:Yarden Y" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Yarden Y" with an ORCID